Cargando…
Metabolic reprogram associated with epithelial-mesenchymal transition in tumor progression and metastasis
Epithelial-mesenchymal Transition (EMT) is a de-differentiation program that imparts tumor cells with the phenotypic and cellular plasticity required for drug resistance, metastasis, and recurrence. This dynamic and reversible events is governed by a network of EMT-transcription factors (EMT-TFs) th...
Autores principales: | Wang, Yifan, Dong, Chenfang, Zhou, Binhua P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Chongqing Medical University
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7083713/ https://www.ncbi.nlm.nih.gov/pubmed/32215287 http://dx.doi.org/10.1016/j.gendis.2019.09.012 |
Ejemplares similares
-
Epithelial-mesenchymal transition in breast cancer progression and metastasis
por: Wang, Yifan, et al.
Publicado: (2011) -
Targeting the Metabolic Reprogramming That Controls Epithelial-to-Mesenchymal Transition in Aggressive Tumors
por: Morandi, Andrea, et al.
Publicado: (2017) -
Role of Metabolic Reprogramming in Epithelial–Mesenchymal Transition (EMT)
por: Kang, Hyunkoo, et al.
Publicado: (2019) -
Twist-mediated Epithelial-mesenchymal Transition Promotes Breast Tumor Cell Invasion via Inhibition of Hippo Pathway
por: Wang, Yifan, et al.
Publicado: (2016) -
Epithelial–mesenchymal transition in tumor metastasis
por: Yeung, Kay T., et al.
Publicado: (2016)